Positronemisjonstomografi i utredningen av lungekreftpasienter

Tore Bach-Gansmo; Trond Velde Bogsrud; Magne Aas; Lars H Jørgensen; Barbara Malene Fischer

Positronemisjonstomografi i utredningen av lungekreftpasienter

Tore Bach-Gansmo, Trond Velde Bogsrud, Magne Aas, Lars H Jørgensen, Barbara Malene Fischer

Abstract

BACKGROUND: Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.

MATERIALS AND METHODS: We have assessed and discuss results recently published in major international journals.

RESULTS: In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.

INTERPRETATION: In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.

Bidragets oversatte titel	Positron emission tomography in the diagnosis of lung cancer
Originalsprog	Norsk
Tidsskrift	Den Norske Laegeforening. Tidsskrift
Vol/bind	124
Udgave nummer	8
Sider (fra-til)	1088-9
Antal sider	2
ISSN	0029-2001
Status	Udgivet - 22 apr. 2004
Udgivet eksternt	Ja

Emneord

Humans
Lung Neoplasms/diagnostic imaging
Meta-Analysis as Topic
Randomized Controlled Trials as Topic
Tomography, Emission-Computed

Citationsformater

@article{3838c840734f4159856872ccff136064,

title = "Positronemisjonstomografi i utredningen av lungekreftpasienter",

abstract = "BACKGROUND: Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.MATERIALS AND METHODS: We have assessed and discuss results recently published in major international journals.RESULTS: In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.INTERPRETATION: In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.",

keywords = "Humans, Lung Neoplasms/diagnostic imaging, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Tomography, Emission-Computed",

author = "Tore Bach-Gansmo and Bogsrud, {Trond Velde} and Magne Aas and J{\o}rgensen, {Lars H} and Fischer, {Barbara Malene}",

year = "2004",

month = apr,

day = "22",

language = "Norsk",

volume = "124",

pages = "1088--9",

journal = "Den Norske Laegeforening. Tidsskrift",

issn = "0029-2001",

publisher = "Norske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Positronemisjonstomografi i utredningen av lungekreftpasienter

AU - Bach-Gansmo, Tore

AU - Bogsrud, Trond Velde

AU - Aas, Magne

AU - Jørgensen, Lars H

AU - Fischer, Barbara Malene

PY - 2004/4/22

Y1 - 2004/4/22

N2 - BACKGROUND: Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.MATERIALS AND METHODS: We have assessed and discuss results recently published in major international journals.RESULTS: In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.INTERPRETATION: In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.

AB - BACKGROUND: Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.MATERIALS AND METHODS: We have assessed and discuss results recently published in major international journals.RESULTS: In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.INTERPRETATION: In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.

KW - Humans

KW - Lung Neoplasms/diagnostic imaging

KW - Meta-Analysis as Topic

KW - Randomized Controlled Trials as Topic

KW - Tomography, Emission-Computed

M3 - Review

C2 - 15114384

SN - 0029-2001

VL - 124

SP - 1088

EP - 1089

JO - Den Norske Laegeforening. Tidsskrift

JF - Den Norske Laegeforening. Tidsskrift

IS - 8

ER -

Positronemisjonstomografi i utredningen av lungekreftpasienter

Abstract

Emneord

Fingeraftryk

Citationsformater